SEHK:512Pharmaceuticals
Assessing Grand Pharmaceutical Group (SEHK:512) Valuation After Recent Earnings And Share Price Pressure
Grand Pharmaceutical Group (SEHK:512) has drawn investor attention after posting annual revenue of HK$11,704.979 million and net income of HK$2,079.449 million, putting fresh focus on how its diversified healthcare business is currently valued.
See our latest analysis for Grand Pharmaceutical Group.
At a share price of HK$7.83, Grand Pharmaceutical Group has seen short term share price pressure, with a 90 day share price return decline of 4.74%. However, its 1 year total shareholder return of...